KI-MSC-PL-205

N/A

Report date: 2024/11/07 11:09:06

Base Information

Drug NameKI-MSC-PL-205
Drug Alias NameAllogeneic Bone Marrow Derived Mesenchymal Stem Cells
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUppsala University
China Registration ClassN/A

Develop Information

Active CompaniesUppsala University HospitalUppsala University
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, AdultCoronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A